Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The 10K annual report should be out in a couple weeks. It appears that they have been doing a great deal of work behind the scenes, and are building value. This thing could be headed back towards .01 soon, it swings quickly and volume is picking up.
How long can they run on the cash can they get from this deal...will it be included in the 10K?
SunEdison has signed a definitive agreement to sell its silicon wafer manufacturing plant in Kuching, Malaysia to China-based LONGi Silicon Materials Corporation.
Silicon wafer manufacturing is largely performed by global manufacturers like LONGi, typically as part of a vertically integrated, high-volume business model. LONGi will operate the facility once it assumes ownership. The sale is expected to close in March 2016, subject to customary conditions and regulatory approvals.
Goldman Sachs Group Inc., Barclays PLC, Citigroup Inc. and UBS Group AG have balked at providing loans they had committed to fund the takeover, according to people familiar with the matter. The banks have told SunEdison its failure to provide them with up-to-date financial statements mean it hasn't fulfilled a condition of the loan agreement, the people said.
SunEdison said in a regulatory filing Monday that it would delay its 2015 earnings report while its board investigates claims from a former and a current employee challenging the accuracy of the company's financial disclosures.
SunEdison said it has found no wrongdoing. The review is still under way and could require the company to "reassess its liquidity position," SunEdison said. A company spokesman declined to comment further Wednesday.
If the Vivint deal hasn't closed by March 18, either side could walk away. SunEdison could line up alternative financing sources for the deal, though its sunken stock price could make it difficult to do so.
SunEdison shares plunged 23% Tuesday before regaining ground Wednesday, recently trading at around $1.70. The stock has lost more than 90% of its value since midsummer on investor concerns about the Vivint transaction and a slide in oil prices that has dragged down energy stocks.
When the deal was announced in July 2015, it was worth $1.9 billion. SunEdison and Vivint later renegotiated the deal, reducing the cash portion. And Vivint's majority shareholder, Blackstone Group LP, agreed to take stock in lieu of cash and to provide SunEdison with a $250 million credit line.
Vivint stockholders, who approved the deal last week, would receive $7.89 a share in cash plus other securities. Its shares were trading around $6.81 Wednesday afternoon.
I can't speak for everyone on this board, but I have a buy in for another 10K shares if it hits $1.50.
I am about 99% positive this will go up as soon as the 10K comes out, and they are free to walk away from Viviant without recourse.
Best of luck!
The price will go back up...the cuts are again tactics to allow SUNE to walk away from the Vivient deal...they are showing how much of a Dire straight they are in, and when the internal investigation completes, all the lights will be back on, and the dividends will be restored. they are currently being held in escrow, and may be rewarded at a later date.
All the buying yesterday in the Millions of Share lots are from those who were selling this past summer...they are ecstatic that the deal is off, and know that the PPS will increase. The reason the PPS tanked in the after hours is because of shorts trying to paint it down...More than 50 Million shares traded in session, only a few hundred thousand traded after hours...
It was a paint job trying to trigger stop losses...plain and simple. Fear causes selling...Those who are buying Millions of shares should be the ones watched, not those who sell a couple thousand.
In My Own Personal Opinion Of Course!
Not hovering at Bankruptcy...
it is just a term to scare banks into not wanting to finance the deal...
makes things look way worse than they are so the deal will not go through.
I absolutely believe that they wanted the deal at first, but once Tepper opened the case, it caused the big sell off because of the "Courts being involved"...people get scared, and want nothing to do with litigation cases...no one wants to go to court and testify, so it was easiest to sell and walk away.
After the shares started dropping in August/September, SUNE thought better of the deal, and found their way out by claiming that there are investigations going on inside the company...thus allowing reporting of financials to be delayed.
We already know they have enough cash to continue for a full year at normal operation rates/production rates.
I will not be surprised at all when the delayed 10K comes out that everything is fully on line, and they have enough cash for years to come. Only after they get to walk away from the Vivient deal on March 18th?
In My Own Personal Opinion Of Course!
To me, it looks pretty obvious that SUNE wants out of the contract as well, but the members of Vivent want their promised PPS in the buyout. Of course they voted in favor of the deal, because the board would have made millions on their held shares. SUNEDISON doesn't need that aspect of the market, they already have a Sunedison semiconductor division that is trading around $6.50 per share...if they really needed money, I am sure that is a viable option to do another merger with in an attempt to produce a cash infusion. After all, they were under one roof at one time before.
SUNE is purposely delaying their annual report until after the deal is fully dissolved. After March 16? I believe, both parties get to walk away with out penalty. Now that the banks have backed out(LOL), and financials are "Delayed" due to internal investigations(LOL), they will have not choice but to let this "Sweet Deal" of acquiring/buying out Vivient go by the wayside.
Is it on purpose...HMMMMMMM...Of Course It Is!
In My Own Personal Opinion Of Course!
New to the stock here, but it looks pretty promising. I do follow many up and coming pharma/biomed companies. Do you know if there were any plans to uplist? Only ask because I know that many institutional investors can't buy anything not listed on the big boards. Some limit to under $1.00 or under $5.00?
Thanks again for your DD.
Great to have people like you on the board!
Pay no attention to that imaginary climb that is or is not awaiting more positive news...
GREAT DD ON SCIE! Thanks 4u2nv2!
I'm sure management sure does believe that they are way undervalued! I'm sure that GC believes his services are way undervalued as well...maybe he should ask for a raise in his salary at the next shareholders meeting as well?
Time to take a little of the rewards...wait for the RSI to settle down again, then maybe buy some of the sold shares back at a lower price...got to love the bounces!
Best of Luck Everyone!
Looks like the day is not over yet?
Climb Baby, Climb!
4.3 Million shares in 5 minutes.....getting busy!
Should still be filed by 16th of March...I'm looking for significant earnings, and bringing the overall value of the company back above a $3.00 PPS...way undervalued here, due to many being scared by a claim by a hedge fund that owns a percentage of one of the subdivisions of SUNE...pathetic!
This thing will bounce hard when it happens...the only selling were the ones who bought in below 1.40 over the past couple months...all the shares bought yesterday and so far today are holding tight, and the Shorts too will have to cover soon...only up from here.
IMHO
IPCI up 9% today to $2.87...should clear $3.00 tomorrow!
working it's way back up towards $1.00 before May!
Debt delayed, positive data across all the trials, new interest in uses daily, many different countries providing positive research...Earnings expected March 3rd, along with a Webcast to discuss financial results and business updates!
Going to be a great few weeks ahead!
This thing has already been a monster!
From 100 to 0 real fast
the proposed amendment to the Corporation’s Articles of Incorporation that increases the number of authorized shares of Common Stock from 150,000,000 shares of Common Stock to no less than 500,000,000 shares of Common Stock.
Common stock outstanding after this offering 51,175,738 shares, assuming all of the Series H Preferred Stock being sold in this offering is converted and the warrants are exercised in full.
$$$ IPCI $$$ Look for 30% Gains today on ANDA FDA Approval!
With 8 more to be approved soon!
http://finance.yahoo.com/news/intellipharmaceutics-announces-fda-approval-500-030344854.html
Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Keppra XR®
$ CYTX $ Look for another big leg up today!
Great Job GC!!! You can almost guarantee another R/S will be following up the end of the Toxic Converts once the PPS drops back down to under .05!
My Best guess is that the PPS will continue to Tank, and Assets will be moved to another shell company or sold to someone that GC can control.
Bye Bye AMBS!
Common stock outstanding after this offering 51,175,738 shares, assuming all of the Series H Preferred Stock being sold in this offering is converted and the warrants are exercised in full.
IPCI moved to Number One on the Break out board!
Looks good to me! :)
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails
U.S. Department of Health and Human Services
FDA, U.S. Food and Drug Administration
U.S. Food & Drug Administration
Drug Name(s) LEVETIRACETAM
FDA Application No. (ANDA) 204511
Active Ingredient(s) LEVETIRACETAM
Company INTELLIPHARMACEUTICS
Original Approval or Tentative Approval Date February 23, 2016
LEVETIRACETAM LEVETIRACETAM 500MG TABLET, EXTENDED RELEASE;ORAL Prescription No AB
LEVETIRACETAM LEVETIRACETAM 750MG TABLET, EXTENDED RELEASE;ORAL Prescription No AB
$CYTX$ Moving up Daily!!
New 2 year data out on Phase II Trials!
Extended timeline to pay back debt!
FDA extended waiver till May for Compliance!
Getting moving in the right direction!
$CYTX$ Still Climbing...Daily!
Number Two on the Break Out Board!
Getting some I-Hub publicity anyway...LOL
Best of Luck everyone!
only took a small position here at 2.20, but happy with the results so far...should be a great 2016!
NEW DRUGS APPROVED! $IPCI$ HUGE GAINS TODAY!!!
Get in while you can...up up up it goes...
very limited Float!
Great News! Loan Payments Deferred! More Money to R&D
http://ih.advfn.com/p.php?pid=nmona&article=70512587
On February 23, 2016, Cytori Therapeutics, Inc. (the "Company") received an acknowledgement and agreement from Oxford Finance LLC, as collateral agent and lender ("Oxford") that Oxford had received evidence, in form and substance reasonably satisfactory to Oxford, that the Company had received positive data on its US ACT-OA clinical trial. As a result, pursuant to the Loan and Security Agreement (the "Loan Agreement"), dated May 29, 2015, with Oxford and the other lenders party thereto from time to time, the period for which the Company is only required to make interest-only payment was extended from June 1, 2016 to January 1, 2017 (the "Amortization Commencement Date"). Following the Amortization Commencement Date, the Company is required to make payments of principal and accrued interest in equal monthly installments sufficient to amortize the Term Loan through June 1, 2019, the maturity date.
Looks like everyone is holding their shares pretty tightly!
Waiting for that Big Jump any day now!
Ahhhhhhhh, love the summer months!
Making that Golden Cross today or tomorrow!
Time to break out a Tourniquet...it is going to be very hard to stop this bleeding!
Look for GC to dump all the assets he wants to keep into other shell companies where he has a chance to make something.
I look for ESS and ELTO to get transferred, all the rest to go down with the Company Name!
Best of Luck everyone...what ever you decide.
I'm out! Dumped my last 250,000 shares at .12 at opening bell...
No Longer Long AMBS!
In My Own Personal Opinion Of Course!
$ CYTX $ NEWS...2 year data published...watch it climb!
All the shareholders are not gone, otherwise this would not be sitting at .004 it looks like there is still believers that the shell will be brought back to life at some point...or they are hoping it will be brought back, just as I am. I for one lost a ton on this one, and didn't sell all my shares before the R/S. So, here's to hoping that Ray and Company start pumping again so I may regain some of my losses from 2015...
It is my honest opinion that Ray will make something of it, just as he does with all the other companies he owns and operates. May not be a legitimate business, but it does make profits if you ride it at 8 seconds at a time...
Best of Luck!
Interest is picking up, money to be made...
.19s are printing, and we could be looking at a quarter by tomorrow...
get while the getting is good, this company will regain compliance and most likely it will be soon! the 2 year data is promising, and when institutional investors get the numbers, the buying will continue by the thousands!
Best of Luck Everyone!
To Regain Compliance by May 31, 2016
http://www.sec.gov/Archives/edgar/data/1095981/000109598116000040/form8k.htm
As previously disclosed, on June 4, 2015, Cytori Therapeutics, Inc. (the "Company") received a deficiency letter from the staff (the "Staff") of The NASDAQ Stock Market LLC ("Nasdaq") notifying the Company that it no longer meets NASDAQ's requirements for continued listing on The NASDAQ Global Market under Nasdaq Listing Rule 5450(a)(1) (the "Bid Price Rule"). The Company was provided until December 1, 2015 to regain compliance with such rules, and on December 3, 2015, the Company received another letter from Nasdaq notifying the Company that it had not regained compliance with such rules within the required time period. The Company appealed Nasdaq's decision to delist its common stock from The NASDAQ Global Market and, pursuant to applicable NASDAQ rules, the delisting of the Company's common stock has been stayed during the pendency of the appeal. As part of its appeal, the Company requested that the listing of its common stock be transferred from The NASDAQ Global Market tier to The NASDAQ Capital Market tier and that the Company be granted additional time to regain compliance with the Bid Price Rule.
On January 27, 2016, the Company received a decision from the Nasdaq Hearings Panel regarding its appeal, which grants the Company's request to transfer the listing of its common stock from The NASDAQ Global Market tier to The NASDAQ Capital Market tier, and grants the Company until May 31, 2016 to regain compliance with the Bid Price Rule. The Company's common stock will continue to trade under the symbol "CYTX" following the transfer of its listing to The NASDAQ Capital Market tier. The continued listing of the Company's common stock on The NASDAQ Capital Market tier is subject to its compliance with the Bid Price Rule on or before May 31, 2016, and its continued compliance with all other applicable rules for continued listing on The NASDAQ Capital Market.
Looking at the most recent 13g/a filings, two more of their debt holders have now been purged.
both Capital Ventures International, and Heights Capital Management, Inc. converted their debt holdings into shares at the rate of 3,723,635 shares each...then dumped on the open market, which possibly explains the decline in PPS over the past couple months. That and the lack of news over the past couple of months as well.
http://ih.advfn.com/p.php?pid=nmona&article=70356025
Now that Debt is being eliminated, and more news is coming to light every day, the PPS should start to stabilize again, and possibly continue to rise. Looks like the bottom was found around .13 ... Should be getting much more interesting around here over the coming months.
Lots of phase II and Phase III trials beginning both in Europe and in the United States.
Working with NASDAQ to avoid the reverse split to continue compliance was a huge concern as well, but after the meeting on 21 January, it is still trading freely on the NASDAQ market.
Best of Luck here, I too have purchased a significant hold.
The outlook here seems to be very good. With a relatively low Outstanding share count, this thing could get moving very quickly with minimal interest.
IMHO
Here's to hoping something will happen...
I'm still personally down about $15K on this one from staying in way too long...I sold all the way down to the R/S(about half my shares), but held after that. Still have many shares, and hope that someone resurrects it and creates interest again...
Best of Luck!
Best guess here is that once MDIN has accumulated as much debt as they can, the "Products"...if that is what you want to call them, will move back to ANAS. Then the Debt will be left in the MDIN shell, and ANAS will come back to life.
IMHO
Did anyone hear updates from the February 10th conference?
Amarantus to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference
PR Newswire
SAN FRANCISCO, February 9, 2016 /PRNewswire/ --
Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, today announced that it will be a featured presenting company at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference which takes place on February 10-11, 2016 in New York City. The Company's presentation will be given on Wednesday, February 10, 2016 at 12:30 pm by Gerald E. Commissiong, President & CEO of Amarantus, in the OneMedMarket Venture Track. The presentation will provide an update on the Company's regulatory interactions with FDA. Amarantus' CEO will be available for one-on-one meetings at the conference.